Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

12. Primary immunodeficiency diseases.

Francisco A Bonilla1, Raif S Geha

  • 1Division of Immunology, Children's Hospital, Enders 809, 300 Longwood Avenue, Boston, MA 02115, USA.

The Journal of Allergy and Clinical Immunology
|February 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The COPI coatomer influences LDL receptor activity, hepatic lipid storage, and apoB secretion.

bioRxiv : the preprint server for biology·2026
Same author

Editorial Expression of Concern: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Nature immunology·2026
Same author

Interleukin-4-producing type 2 innate lymphoid cells in the lymph node promote proallergic Tfh13 cell differentiation.

Immunity·2026
Same author

Hidden immune memory niches in inflammatory skin diseases.

bioRxiv : the preprint server for biology·2026
Same author

Multi-modal skin atlas identifies a multicellular immune-stromal community associated with disrupted cornification and specific T cell expansion in atopic dermatitis.

Nature communications·2026
Same author

Basophils in atopic dermatitis: Immunologic roles and clinical implications.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2025
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
Same journal

Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug Payload.

The Journal of allergy and clinical immunology·2026
Same journal

Loss of epidermal miR-149 sensitizes to skin inflammation.

The Journal of allergy and clinical immunology·2026
See all related articles

Primary immunodeficiency disorders, though rare, offer insights into immunity, inflammation, and autoimmunity. Early diagnosis and treatment are crucial for improved outcomes and genetic counseling.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Primary immunodeficiency disorders (PIDs) are rare but provide critical insights into host defense, inflammation, and autoimmunity.
  • Research into PIDs has advanced understanding applicable to secondary immunocompromised states, autoimmune disorders, and transplant medicine.
  • The successful correction of severe combined immunodeficiency through gene therapy highlights therapeutic potential.

Purpose of the Study:

  • To review the major clinical manifestations of primary immunodeficiency disorders.
  • To describe the molecular pathophysiology of PIDs.
  • To present key treatment concepts for PIDs.

Main Methods:

  • This is a review article, synthesizing existing knowledge.
  • It focuses on molecular-level pathophysiology.

Related Experiment Videos

  • Clinical manifestations and treatment strategies are discussed.

    • Main Results:

    • Intensive investigation of PIDs has significantly advanced basic immunologic understanding.
    • Developments in PID treatment benefit various immune-related conditions.
    • Gene therapy for severe combined immunodeficiency is a landmark achievement.

    Conclusions:

    • Early diagnosis of PIDs is critical for reducing morbidity and improving survival.
    • Primary care providers and allergists must maintain a high index of suspicion for immunodeficiency.
    • Accurate diagnosis is essential for effective genetic counseling and management.